「极养视界」科普实验室 原创出品 授权方可转载 作者|Penny MS 校稿|Haoran PHD 编审|Xinyin PHD, RD 设计|Fay 阅读信息 📖 难度:★★☆☆☆ 类型:一图读懂 点击查看高清图文 ▼ ■■
■■ 《极养日历 2021|湖水历》 现货出售 ⛰️ 点击获取上线优惠 ■■ 参考文献 [1] Fan L, Feng Y, Chen G, Qin L, Fu C, Chen L. Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research. 2017;119:128-136. doi:10.1016/j.phrs.2017.01.032. [2] Zhai J, Bo Y, Lu Y, Liu C, Zhang L. Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis. PLOS ONE. 2017;12(1):e0170172. doi:10.1371/journal.pone.0170172. [3] Sale ST, Parvez H, Yeltiwar RK, Vivekanandan G, Pundir AJ, Jain P. A comparative evaluation of topical and intrasulcular application of coenzyme Q10 gel in chronic periodontitis patients: A clinical study. J Indian Soc Periodontol. 2014 Jul;18(4):461-5. doi: 10.4103/0972-124X.138690. [4] Mortensen S, Rosenfeldt F, Kumar A et al. The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure. JACC: Heart Failure. 2014;2(6):641-649. doi:10.1016/j.jchf.2014.06.008. [5] DiNicolantonio J, Bhutani J, McCarty M, O'Keefe J. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart. 2015;2(1):e000326. doi:10.1136/openhrt-2015-000326. [6] Shao L, Ma A, Figtree G, Zhang P. Combination Therapy With Coenzyme Q10 and Trimetazidine in Patients With Acute Viral Myocarditis. Journal of Cardiovascular Pharmacology. 2016;68(2):150-154. doi:10.1097/fjc.0000000000000396. [7] Lei L, Liu Y. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovascular Disorders. 2017;17(1). doi:10.1186/s12872-017-0628-9. [8] Busanello E, Marques A, Lander N et al. Pravastatin Chronic Treatment Sensitizes Hypercholesterolemic Mice Muscle to Mitochondrial Permeability Transition: Protection by Creatine or Coenzyme Q10. Frontiers in Pharmacology. 2017;8. doi:10.3389/fphar.2017.00185. [9] Okeahialam B. Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report. Vascular Health and Risk Management. 2015:579. doi:10.2147/vhrm.s90551. [10] Suksomboon N, Poolsup N, Juanak N. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics. 2015;40(4):413-418. doi:10.1111/jcpt.12280. [11] Henriksen JE, Andersen CB, Hother-Nielsen O, Vaag A, Mortensen SA, Beck-Nielsen H. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet Med. 1999;16(4):312-318. [12] Xu Z, Huo J, Ding X et al. Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition. Scientific Reports. 2017;7(1). doi:10.1038/s41598-017-08899-7. [13] Sikorska M, Lanthier P, Miller H et al. Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease. Neurobiology of Aging. 2014;35(10):2329-2346. doi:10.1016/j.neurobiolaging.2014.03.032. [14] Muthukumaran K, Leahy S, Harrison K et al. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease. BMC Neuroscience. 2014;15(1):21. doi:10.1186/1471-2202-15-21. [15] Parkinson Study Group QE3 Investigators, Beal M, Oakes D et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014;71(5):543-52. doi:10.1001/jamaneurol.2014.131. [16] Zhu Z, Sun M, Zhang W, Wang W, Jin Y, Xie C. The efficacy and safety of coenzyme Q10 in Parkinson’s disease: a meta-analysis of randomized controlled trials. Neurological Sciences. 2016;38(2):215-224. doi:10.1007/s10072-016-2757-9. [17] Negida A, Menshawy A, El Ashal G et al. Coenzyme Q10 for Patients with Parkinson';s Disease: A Systematic Review and Meta-Analysis. CNS & Neurological Disorders - Drug Targets. 2016;15(1):45-53. doi:10.2174/1871527314666150821103306. [18] Bjørklund G. The Adjuvant Nutritional Intervention in Cancer (ANICA) Trial. Nutrition and Cancer. 2015;67(8):1357-1360. doi:10.1080/01635581.2015.1085582. [19] Liu H, Cheng S, Huang Y, Huang Y, Lin P. Coenzyme Q10 and Oxidative Stress: Inflammation Status in Hepatocellular Carcinoma Patients after Surgery. Nutrients. 2017;9(1):29. doi:10.3390/nu9010029. [20] Tafazoli A. Coenzyme Q10 in breast cancer care. Future Oncology. 2017;13(11):1035-1041. doi:10.2217/fon-2016-0547. [21] Landbo C, Almdal TP. Interaction between warfarin and coenzyme Q10. Ugeskr Laeger. 1998 May;160(22) 3226-3227. PMID: 9621803. [22] Tarry-Adkins JL, Fernandez-Twinn DS, Madsen R, et al. Coenzyme Q10 Prevents Insulin Signaling Dysregulation and Inflammation Prior to Development of Insulin Resistance in Male Offspring of a Rat Model of Poor Maternal Nutrition and Accelerated Postnatal Growth. Endocrinology. 2015;156(10):3528-3537. doi:10.1210/en.2015-1424. |
|